OQROGet OQRO Pro
Insider trade

Alx Oncology (ALXO)Officer sold ~$1.3K

Shelly Pinto, Officer at Alx Oncology, sold ~$1.3K of Alx Oncology shares.

~$1.3K
Approx. value · 565 sh @ $2.27
88K
Holds after · shares reported
Traded
Feb 18, 2026
Filed
Feb 20, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 6, 2026InsiderOfficer sold ~$4.4K of ALXO shares in the open market
  2. Jan 21, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective January 21, 2026, the Board of Directors (the “Board”) of ALX Oncology Holdings Inc. (the “Company”) amended the 2025 Inducement Equity Incentive Plan (the “Inducement Plan”) to increase the number of shares reserved for issuance under the Inducement Plan.”
  3. Jan 30, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  4. Feb 2, 2026Insider · First buy since 2020Director purchased ~$5M of ALXO shares in the open market
  5. Feb 18, 2026 · this disclosureInsiderOfficer sold ~$1.3K of ALXO shares in the open market

What came next

  1. Feb 27, 2026Company filing · Form 8-K · ResultsReported its results
  2. Mar 19, 2026Insider · 2 peopleInsiders: 2 sales (~$29K)
  3. Apr 13, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Effective April 13, 2026, the Board of Directors (the “Board”) of ALX Oncology Holdings Inc. (the “Company”) appointed Jeff Knight as Chief Development and Operating Officer.”
  4. May 8, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Alx Oncology

For Alx Oncology, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALXO page.

Other recent filings by Shelly Pinto, SVP, FINANCE AND CAO

The full history of Shelly Pinto, SVP, FINANCE AND CAO is on the profile page.

How this filing works

Other disclosures at Alx Oncology

Everything OQRO holds on this company is on its ALXO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data